In this sense, elevated circulating ACE2 levels have been reported in different cohorts of COVID-19 patients, suggesting a relation between clinical course and ACE2 levels either in acute or long-term disease [12,13,14,15], although data needs further validation. Here, ACE2 is linked to COVID-19.